The expanding landscape of GLP-1 medicines

Nature Medicine, Published online: 02 January 2026; doi:10.1038/s41591-025-04124-5 This Review discusses the expansion of glucagon-like peptide-1 (GLP-1) medicines beyond type 2 diabetes and obesity, outlining opportunities for new indications, key questions around benefits and long-term safety, and areas of uncertainty requiring further research.

The good health news that could improve your life in 2026

This is Everyday Science with Clare Wilson, a subscriber-only newsletter from The i Paper. If you’d like to get this direct to your inbox every week, you can sign up here. Hello, and welcome back to Everyday Science. Are you in a post-Christmas slump? If so, lift your spirits by reading some good news, the progress that has been […]

Twenty Twenty-Five

2025 was… a year. And I made it to the end of that year. If you’re reading this, I imagine you did too and let’s celebrate that. But also not one without loss; of loved ones, of health, of relationships, of jobs, of liberties, of pursuits of happiness. Let’s mourn those. My year was mundane […]

What’s ahead for the weight-loss drugs known as GLP-1s in 2026 – NPR

What’s ahead for the weight-loss drugs known as GLP-1s in 2026  NPR 2026 will bring more GLP-1 weight loss pills — and new habits. These stocks are poised to benefit  CNBC What to watch for in weight loss drugs in 2026: Price changes, GLP-1 pills and more  NBC News The weight-loss drugs on trial in 2026 may trump […]

The bio-pirate’s guide to GLP-1 agonists

Published on January 2, 2026 3:32 AM GMT How to lose weight, infringe patents, and possibly poison yourself for 22 Euros a month. Introduction In March 2025, Scott Alexander wrote: Others are turning amateur chemist. You can order GLP-1 peptides from China for cheap. Once you have the peptide, all you have to do is […]